Skip to main content
USAQ
OTC Life Sciences

QHSLab Posts $457K Net Income, 26% Revenue Growth, and Slashes Debt by $2M

feedReported by Wiseek News
Sentiment info
Positive
Importance info
9
Price
$0.57
Mkt Cap
$6.43M
52W Low
$0.08
52W High
$1.136
Market data snapshot near publication time

summarizeSummary

QHSLab, Inc. reported robust fiscal 2025 financial results, swinging to a net income of $457,417 from a prior-year loss, driven by a 26% increase in revenue to $2.69 million. The company also significantly strengthened its balance sheet by reducing current liabilities from approximately $2.4 million to $450,000, largely due to debt repurchases and restructuring, including a $1.15 million gain on extinguishment of convertible debt. These strong results, including a move to profitability and substantial debt reduction, are highly material for a micro-cap company and could lead to a significant positive re-evaluation of its stock. Investors will be watching for sustained profitability and continued operational expansion.

At the time of this announcement, USAQ was trading at $0.57 on OTC in the Life Sciences sector, with a market capitalization of approximately $6.4M. The 52-week trading range was $0.08 to $1.14. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


show_chartPrice Chart

Share this article

Copied!

feed USAQ - Latest Insights

USAQ
Apr 27, 2026, 3:36 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
USAQ
Apr 21, 2026, 9:15 AM EDT
Filing Type: 8-K
Importance Score:
8
USAQ
Mar 31, 2026, 8:33 AM EDT
Source: Wiseek News
Importance Score:
9